ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,384Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 41

$1.06M Total Retail Price of All Prescriptions

Rank: 1 out of 41

860 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 860 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

8% of this provider’s 860 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

2% of this provider’s 7,416 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

46% of this provider’s prescriptions were for brand-name drugs, compared to an average of 60%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $132 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
PROAIR HFA 1,053 475 1 3
ADVAIR DISKUS 786 409 2 2
FUROSEMIDE 630 374 3 9
SPIRIVA 586 244 4 1
PREDNISONE 529 318 5 4
SYMBICORT 499 255 6 5
HYDROCODONE-ACETAMINOPHEN 459 329 S3 7 13
THEOPHYLLINE ANHYDROUS 451 240 8 8
SINGULAIR 326 185 9 6
VENTOLIN HFA 314 179 10 18
POTASSIUM CHLORIDE 313 198 11 21
DOXYCYCLINE HYCLATE 297 153 12 48
COMBIVENT 275 136 13 19
LEVOFLOXACIN 244 137 14 28
QVAR 239 126 15 31
OMEPRAZOLE 237 145 16 7
MONTELUKAST SODIUM 213 122 17 10
METHYLPREDNISOLONE 199 93 18 32
ZOLPIDEM TARTRATE 181 95 19 23
FLUTICASONE PROPIONATE 160 110 20 11
KLOR-CON M20 143 80 21 52
DIGOXIN 138 106 22 51
AZITHROMYCIN 138 66 22 14
TRAMADOL HCL 130 104 24 41
DULERA 128 27 25 61
KLOR-CON M10 127 91 26 64
ENALAPRIL MALEATE 126 81 27 46
ADVAIR HFA 117 59 28 45
FLOVENT HFA 115 88 29 36
GABAPENTIN 111 57 30 29
PROVENTIL HFA 106 59 31 78
DILTIAZEM 24HR CD 99 63 32 66
NEXIUM 98 54 33 26
DEXILANT 94 79 34 82
SIMVASTATIN 92 54 35 15
LEVOTHYROXINE SODIUM 90 63 36 12
METOPROLOL TARTRATE 88 51 37 24
TRAZODONE HCL 86 57 38 44
METFORMIN HCL 84 52 39 20
WARFARIN SODIUM 80 20 40 22
ASMANEX 80 55 40 53
RANITIDINE HCL 77 31 42 39
CITALOPRAM HBR 76 45 43 50
MEGESTROL ACETATE 73 44 R 44 90
ALENDRONATE SODIUM 72 56 45 60
ATROVENT HFA 71 30 46 92
AMLODIPINE BESYLATE 71 34 46 16
ISOSORBIDE MONONITRATE ER 70 35 48 35
DILTIAZEM 24HR ER 69 17 49 94
TAMSULOSIN HCL 62 60 50 54
ZAFIRLUKAST 60 13 51 102
NASONEX 59 22 52 69
ROPINIROLE HCL 56 0 53 30
LISINOPRIL 52 0 54 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 23 55 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 2, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.